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              Interleukin-1 (IL-1) mediates diverse neurophysiological and neuropathological effects 3 
in the central nervous system (CNS) through type I IL-1 receptor (IL-1R1). However, 4 
identification of IL-1R1 expressing cell types and cell type specific functions of IL-1R1 remains 5 
challenging. In this study, we created a novel genetic mouse model in which IL-1R1 gene 6 
expression is disrupted by an intronic insertion of a loxP flanked disruptive sequence that can 7 
be deleted by Cre recombinase, resulting in restored IL-1R1 gene expression under its 8 
endogenous promoters. A second mutation was introduced at stop codon of the IL-1R1 gene to 9 
allow tracking of the restored IL-1R1 protein by a 3HA tag and IL-1R1 mRNA by tdTomato 10 
fluorescence. These animals were designated as IL-1R1r/r and exhibited an IL-1R1 knockout 11 
phenotype. We used IL-1R1 globally restored mice (IL-1R1GR/GR) as an IL-1R1 reporter and 12 
observed concordant labeling of IL-1R1 mRNA and protein in brain endothelial cells. Two cell 13 
type specific IL-1R1 restore lines were generated: Tie2Cre-IL-1R1r/r and LysMCre-IL-1R1r/r.  14 
Brain endothelial COX-2 expression, CNS leukocyte infiltration and global microglia activation 15 
induced by intracerebroventricular injection of IL-1β, were not observed in IL-1R1r/r or LysMCre-16 
IL-1R1r/r mice but were restored in Tie2Cre-IL-1R1r/r mice. These results reveal IL-1R1 17 
expression in endothelial cells alone is sufficient to mediate these central IL-1 induced 18 
responses. In addition, ex vivo IL-1β stimulation increased IL-1β expression in bone marrow 19 
cells in wild type, Tie2Cre-IL-1R1r/r, and LysMCre-IL-1R1r/r, but not IL-1R1r/r mice. These results 20 
demonstrate this IL-1R1 restore model is a valuable tool for studying cell type specific functions 21 






1. INTRODUCTION  1 
 Interleukin 1 (IL-1) is involved in many neuroimmune responses such as fever, HPA-axis 2 
activation, sickness behavior, and prolonged slow wave sleep (Sheng et al., 1994; Dunn, 2000; 3 
Rothwell, 2003; Dube et al., 2005). In addition, IL-1 signaling contributes to CNS wound healing 4 
process (Griffin et al., 1994; Mason et al., 2001), stress induced learning and memory 5 
impairments (Schneider et al., 1998; Rachal Pugh et al., 2001), and neurodegenerative 6 
processes (Shaftel et al., 2008). Most of these actions are mediated through the type I IL-1 7 
receptor (IL-1R1). One explanation for the diverse range of IL-1R1 mediated activities is IL-1R1 8 
produces distinct responses in different cell types. For example, in cultured human microglia 9 
numerous proinflammatory cytokines, such as IL-1β, IL-6, and TNF-α, are produced following 10 
IL-1 stimulation (Lee et al., 1993). These proinflammatory cytokines can cause exacerbation of 11 
neuroinflammation. Conversely, in cultured rat astrocytes, a study showed IL-1 stimulates 12 
astrocytes to release nerve growth factor which can mediate neuroprotective effects (Gadient et 13 
al., 1990). In addition, administration of IL-1 in the cerebral ventricle induced cyclooxygenase 2 14 
(COX-2) exclusively in endothelial cells comprising brain blood vessels to mediate fever (Cao et 15 
al., 2001). Therefore, depending on the cell type, IL-1 induces different neuromodulatory 16 
molecules and functions. The precise mechanisms of how IL-1 activates specific cell types in 17 
vivo remains to be determined.  18 
One difficulty in regards to the analysis of IL-1R1 mediated functions is visualization of 19 
IL-1R1 expressing cells. In situ hybridization histochemistry (ISHH) has found IL-1R1 mRNA in 20 
rat brain endothelial cells (Konsman et al., 2004) and neurons in select brain regions, including 21 
basolateral nucleus of the amygdala, arcuate nucleus of the hypothalamus, trigeminal and 22 
hypoglossal motor nuclei, and area postrema (Cunningham and De Souza, 1993; Ericsson et al., 23 
1995). However, studies using immunohistochemistry (IHC) to detect IL-1R1 protein have 24 
generated discrepant results. IL-1R1 immunoreactivity (IL-1R1-ir) has been found in endothelial 25 
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cells in both rats and mice (Konsman et al., 2004; Matsuwaki et al., 2014) and in astrocytes in 1 
rats (Ravizza and Vezzani, 2006). On the contrary, there is a report showing IL-1R1-ir was 2 
exclusively found in neurons but not endothelial cells (French et al., 1999). These discrepancies 3 
could result from the current limitations of IHC for detecting low levels of IL-1R1. However, it is 4 
known that less than 20 IL-1R1 molecules per cell are sufficient to mediate IL-1 signaling (Sims 5 
et al., 1993). Therefore, increasing the sensitivity for the detection of IL-1R1 protein could 6 
significantly facilitate the visualization of these molecules. 7 
 In this study, we created a novel genetic mouse model (i.e., IL-1R1 restore) which allows 8 
the selective expression of IL-1R1 on a defined cell type using its endogenous promoters. IL-9 
1R1 mRNA and protein expression can be tracked simultaneously in this model by genetic 10 
insertion of tdTomato and 3HA tag respectively. Following characterization of this newly 11 
generated mouse model, we have identified endothelial cells as the main producer of IL-1R1 in 12 
the brain and IL-1R1 expression in endothelial cells alone is sufficient to mediate several IL-1 13 
induced responses in the CNS.  14 
  15 
2. METHODS 16 
2.1. Generation of IL-1R1 restore mice 17 
 The bacterial artificial chromosome (BAC) clone bMQ-81D08 containing the full mouse 18 
genomic IL-1R1 region was purchased from Source BioScience (Nottingham, UK). A 22.4kb 19 
DNA fragment containing IL-1R1 exon VII to exon XI was retrieved into the vector PL253 20 
(ATCC® PTA-4998™, Manassas, VA) by homologous recombineering. Two intended mutation 21 
DNA segments were designated as knockin target I and target II (Fig. 1). The target I segment 22 
contained a mouse Engrailed-2 splice acceptor sequence (En2), a destabilization domain (DD), 23 
and 2PolyA signal sequence followed by a Neo cassette. The En2 sequence has been used to 24 
disrupt gene expression when inserted into an intron (Tsakiridis et al., 2007); the DD sequence 25 
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encodes a peptide tag that would destabilize the IL-1R1 molecule (Iwamoto et al., 2010) even if 1 
the En2 insertion fails to interrupt IL-1R1 gene expression; the 2PolyA sequence causes a 2 
transcriptional stop to prevent further synthesis of downstream IL-1R1 preRNA (Proudfoot, 3 
2011). The Neo cassette was added for later positive selection of the inserted sequence. These 4 
interfering insertional elements were flanked by two loxP sites. The target I sequence was 5 
generated by PCR amplification of the above described sequences and sequential subcloning 6 
into the pBluescript II SK(+) vector (Agilent Technologies, Santa Clara, CA). Using the same 7 
strategy, the knockin target II was constructed. In knockin target II the original IL-1R1 stop 8 
codon was replaced by 3HA-STOP-IRES-tdTomato-STOP. The 3HA tag has been used to 9 
facilitate the detection of proteins with low expression level (Lobbestael et al., 2010). When 10 
added after a stop codon, the IRES-tdTomato can track the mRNA of targeted gene 11 
independent of its translation (Hellen and Sarnow, 2001; Shaner et al., 2004).  Target I and 12 
target II were incorporated into PL253 vector by two rounds of homologous recombineering. 13 
Gene allele containing both target I and target II sequences was designated as IL-1R1 restore 14 
(IL-1R1r) allele. By this design, mice containing the knockin target I in the IL-1R1 intron IX will 15 
not be able to produce functional IL-1R1 protein. However, once this mouse is mated with a 16 
mouse containing cell-type specific Cre, the target I will be excised, ultimately restoring IL-1R1 17 
only in the Cre-targeted cell type. The restored IL-1R1 gene will have its mRNA tracked by 18 
tdTomato fluorescence and protein tracked by 3HA epitopes (Fig. 1).  19 
The entire construct was verified by sequencing, then transfected into mouse embryonic 20 
stem (ES) cells. ES cell colonies were screened by SacI digestion followed by Southern blot 21 
analysis using a 5’ probe and a 3’ probe. The 5’ probe detects a 15 kb DNA fragment whereas 22 
the 3’ probe detects an 8.7 kb DNA fragment in the target allele according to the design in Fig. 1. 23 
Both probes detect a 22 kb fragment in the wild type allele. ES cells with successful 24 
homologous recombination were injected into blastocysts to generate a mouse carrying an IL-25 
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1R1r allele. Mice in which the IL-1R1r allele was transmitted to the germ line was obtained and 1 
confirmed by Southern blot.  2 
 3 
2.2. Animals 4 
Once a C57BL/6 founder mouse with IL-1R1r germ line transmission was obtained, it 5 
was bred to generate IL-1R1r/+ and IL-1R1r/r mice. Cell type specific Tie2Cre-IL-1R1r/r mice and 6 
LysMCre-IL-1R1r/r mice were generated by crossbreeding Tie2Cre-IL-1R1+/+ transgenic mice 7 
(Jackson Laboratories, Bar Harbor, ME; stock No.004128) or LysMCre-IL-1R1+/+ mice (Jackson 8 
Laboratories, Bar Harbor, ME; stock No.018956) with IL-1R1r/r mice. In a previous study, Koni et 9 
al. had characterized the Tie2Cre transgenic line used in the current study (Koni et al., 2001). 10 
They found the male Tie2Cre transgene carrier deletes loxP flanked sequence in hematopoietic 11 
cells and endothelial cells, whereas female Tie2Cre carrier deletes the loxP flanked sequence in 12 
the germ line of the offspring, which resulted in a global deletion of the loxP flanked sequence in 13 
the next generation without further need of Cre mediated deletion. Therefore to maintain our 14 
Tie2Cre-IL-1R1r/r line, only male Tie2Cre-IL-1R1r/r mice were used as the Tie2Cre carrier. A 15 
female Tie2Cre-IL-1R1r/r animal was also used to mate with a male IL-1R1r/r animal to generate 16 
an IL-1R1 globally restored heterozygote (IL-1R1GR/r) animals. The designation GR indicates 17 
that the IL-1R1 restored sequence is in all cell types. Animals with IL-1R1GR will have the IL-1R1 18 
restored without the presence of Cre. IL-1R1 globally restored homozygote (IL-1R1GR/GR) 19 
animals were obtained by breeding the IL-1R1GR/r animals with each other. All procedures were 20 
approved by The Ohio State University Animal Care and Use Committee. 21 
 22 
2.3. Genotyping  23 
 Genomic DNA was purified from mouse tail tissue using a protocol described previously 24 
(An et al., 2014). Briefly, a 5 mm mouse tail biopsy was incubated in 500 µl lysis buffer for 2 hrs 25 
at 56°C with repeated agitation. The lysis buffer contained 10 mM Tris-HCl, pH 8.0, 100 mM 26 
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EDTA, 0.5% SDS, 0.2 mg/ml ribonuclease A (Invitrogen, Carlsbad, CA), 1 mg/ml proteinase K 1 
(Invitrogen, Carlsbad, CA). Samples were centrifuged at 13,000 rpm for 10 min to remove tissue 2 
residue. Supernatants were removed and gently mixed with 500 µl isopropanol. Genomic DNA 3 
was then pelleted and washed with ice-cold 70% ethanol. DNA pellets were air dried and 4 
dissolved in 50 µl of DNAse free water.   5 
 To detect the knock-in IL-1R1 allele (IL-1R1r), the inserted DNA segment target I and 6 
target II were separately detected using the following primers: for target 1 (sequence T1, Fig. 7 
3A), T1F1 5’-ATAAGAATGCGGCCGCTAAAGTATGTTTTTGAAATAGAAAAGATTG-3’ and 8 
T1R2 5’- ACCGGAATTCCGCGTTCTTCTTCTTTGGTTTTCGGG-3’; for target 2 (sequence T2, 9 
Fig. 3A), T2F1 5’-GCAGAAACACGGAGTCATTTGCTGGTCAGG-3’ and T2R2 5’-10 
CTCGTCAAGAAGACAGGGCCAG-3’. Two additional sets of primers were designed to detect 11 
wild type IL-1R1 sequence to distinguish homozygote (IL-1R1r/r) from heterozygote (IL-1R1r/+) 12 
animals: for wild type sequence corresponding to the target 1 locus (sequence T1WT, Fig. 3A), 13 
T1F1 and T1R1 5’-ACCGCTCGAGATCAGAGATGAAATGACTACAAGCTGTC-3’; for wild type 14 
sequence corresponding to the target 2 locus (sequence T2WT, Fig. 3A)，T2F1 and T2R1 5’-15 
GAGCAGCATCCCTGAGCAACCATGGCTCTCTG-3’ (Note the forward primers T1F1 and T2F1 16 
were the same as those used for T1 and T2 respectively). After Cre mediated excision of target 17 
1, the restored IL-1R1 allele (IL-1R1R) was detected by the following primers: LoxPF1 5’-18 
ACAGTCTCTGCAGATAACTTCGTATA-3’ and T1R1 (described above). To detect the presence 19 
of Cre recombinase, the following primers were used: CreF 5’-CGATGCAACGAGTGATGAGG-20 
3’ and CreR 5’-CGCATAACCAGTGAAACAGC-3’.  21 
 Quantitative RT-PCR was performed to compare IL-1R1 globally restored genotype (IL-22 
1R1GR) with cell type specific IL-1R1 restored genotype. The restored amplicon (primers LoxPF1 23 
and T1R1) was amplified using SYBER green quantitative PCR from 1 µg tail genomic DNA 24 
from IL-1R1GR/GR, IL-1R1GR/r, Tie2Cre-IL-1R1r/r, LysMCre-IL-1R1r/r and IL-1R1r/r mice. 25 
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Amplification curves were recorded by an ABI PRISM 7500 sequence detection system (Applied 1 
Biosystems, Foster, CA). 2 
 3 
2.4. Intracerebroventricular (ICV) injection of IL-1β 4 
ICV injections were conducted as described previously (Ching et al., 2007). Briefly, 8-10 5 
week old animals weighing 20-30 g were anesthetized by intraperitoneal injection of 100 mg/kg 6 
Nebutal (Abbott Laboratories, North Chicago, IL). Animals were then fastened onto an animal 7 
stereotaxic (David Kopf Instruments, Tujunga, CA).  A 28 gauge guide cannula was inserted into 8 
the right lateral ventricle [anteroposterior (AP), -1 mm; mediolateral (ML), -0.7 mm; dorsoventral 9 
(DV), -2.7 mm]. Using a microinjection system, 20 ng of IL-1β (R&D Systems, Minneapolis, MN) 10 
dissolved in 10 µl sterile PBS was infused into the ventricle at rate of 0.8 µl/min (KDS Scientific, 11 
Holliston, MA). Wounds were closed with surgical staples. After animals recovered from the 12 
surgery, they were sacrificed at 4 h, 12 h or 24 h post-surgery. 13 
 14 
2.5. Immunohistochemistry  15 
 For 3HA, Iba-1, GFAP and Ly6C labeling, animals were perfusion fixed with 4% 16 
formaldehyde. Brains were removed, post-fixed in 4% formaldehyde for 24 hrs and incubated in 17 
20% sucrose at 4 °C for 24 hrs. Brains were then quickly frozen on dry ice and 30-µm thick 18 
coronal sections were generated with a cryostat. Sections were directly examined for tdTomato 19 
fluorescence by fluorescent microscopy. For double labeling of other cell markers, sections 20 
were incubated with 1% sodium borohydride and 0.5% hydrogen peroxide to reduce 21 
background. They were incubated with anti-3HA (1:500; rabbit anti-mouse, Cat# 3724; Cell 22 
Signaling, Danvers, MA), anti-Iba1 (1:1000; rabbit anti-mouse, Cat# 019-19741; Wako 23 
Chemicals, Richmond, VA), anti-GFAP (1:1000; rabbit anti-mouse, Cat# z0334; Dako, 24 
Carpinteria, CA) or anti-Ly6C antibody (1:500; rat anti-mouse, Cat# ab54223; Abcam, 25 
Cambridge, MA), followed by biotinylated secondary antibody and visualized by Cy2-26 
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streptavidin (Jackson Immunoresearch, West Grove, PA). For 3HA staining, tyramide signal 1 
amplification procedure was performed (PerkinElmer, Waltham, MA).  2 
 For COX-2 and CD45 labeling, mice brains were collected at 4 hrs (COX-2) and 12 hrs 3 
(CD45) after ICV injections and frozen coronal sections were fixed in acetone/alcohol mixture, 4 
followed by incubation in a glucose oxidase and sodium azide solution. After incubation with 5 
anti-COX-2 (1:200; rabbit anti-mouse, Cat# 160106; Cayman Chemicals, Ann Arbor, MI) or anti-6 
CD45 (1:500; rat anti-mouse, Cat# 550539; BD Pharmingen, Franklin Lakes, NJ) primary 7 
antibody and anti-rabbit/anti-rat secondary antibody, labeling was amplified using an ABC 8 
solution (Vector Laboratories, Burlingame, CA) and then visualized with a diaminobenzidine 9 
(DAB) peroxidase substrate kit (Vector Laboratories, Burlingame, CA).  10 
 11 
2.6. Immunofluorescence imaging and processing 12 
 IHC results were examined using different microscopes. For sections visualized by DAB 13 
peroxidase substrate kit, results were obtained using a Leica DM5000B microscope connected 14 
to a Leica DFC300 FX camera and imaging software. For all the immunofluorescence imaging, 15 
confocal images were captured using a Zeiss LSM510. Images were optimized for color, 16 
brightness and contrast for best clarity. Multiple-channel images were overlaid and 3d-17 
reconstructed using ImageJ (National Institutes of Health, Bethesda, MD, USA). For IL-1R1 18 
mRNA distribution mapping, confocal images with overlapping anatomical marks were taken 19 
from an IL-1R1GR/GR animal. Then images were combined and spliced to produce a collage of 20 
the brain sections using Adobe PhotoshopTM 6.0. 21 
 22 
2.7. Quantification and proportional area analysis of microglia 23 
 For proportional area analysis of microglia, a protocol from previous literature (Donnelly 24 
et al., 2009) was performed. In brief, representative images were obtained at 20x magnification. 25 
A threshold for positive staining was determined for each image and processed with 26 
10 
 
densitometric scanning using ImageJ (National Institutes of Health, Bethesda, MD, USA). 1 
Average percentage area in the positive threshold was calculated for all the pictures. 2 
 Numbers of microglia cell bodies were counted from Iba-1 stained sections. Pictures 3 
were adjusted to similar background level with ImageJ before counting. Three randomly 4 
selected regions containing more than 30 microglia in the area of interest were examined.  5 
 6 
2.8. Brain endothelial cell enrichment and flow cytometry  7 
 Brain endothelial cells were enriched using a modified protocol described by Motoike et 8 
al. (Motoike et al., 2000). In brief, IL-1R1r/r, IL-1R1GR/GR or IL-1R1GR/r animals were first 9 
intracardially perfused with PBS. Brains were then dissected and minced into 1 mm fragments 10 
with a razor blade.  Tissue was then incubated on a shaker plate at 37°C in pre-warmed PBS 11 
with Collagenase I (5 mg/ml) and DNase I (120 U/ml) (Worthington, Lakewood, NJ) for 12 
approximately 70 min until all the tissue was digested. Cells were pipetted every 10 min during 13 
the incubation. At the end of digestion, DMEM containing 10% FBS was added to the cell 14 
suspension to neutralize the collagenase activity. Cells were gently pelleted (900 x g, 6 min) and 15 
resuspended with 15 ml 25% BSA/PBS. They were then filtered through a 70 µm mesh cell 16 
strainer and centrifuged at 2000 x g for 20 min at RT. The dense white myelin layer on the 17 
surface was carefully removed by pipetting. Cells were resuspended in PBS containing 0.5 mM 18 
EDTA, 60 U/ml DNase I and 3% FBS and kept on ice. All solutions and tissue were kept in dark 19 
or covered with a black box during digestion and processing to minimize bleaching of tdTomato 20 
fluorescence.  21 
 For flow cytometric analysis, Fc receptors were blocked with anti-CD16/CD32 antibody 22 
(eBioscience, San Diego, CA) for 10 min. Cells were then labeled with fluorescent monocolonal 23 
anti-CD31 antibody (eBioscience, San Diego, CA) or isotype control for 45 min at 4°C. Cells 24 
were then washed and resuspended in FACS buffer containing 2% FBS in HBSS and 1 μg/ml 25 
sodium azide. Cell suspensions were filtered again before cytometric analysis. Approximately 26 
11 
 
1x104 events were analyzed using a Becton-Dickinson FACSCaliber (BD Biosciences, San 1 
Jose, CA). Data were subsequently analyzed using FlowJo (Treestar; Ashland, OR).  2 
 3 
2.9. Bone marrow cell isolation and ex vivo IL-1β challenge 4 
 Femurs from experimental animals were excised and epiphyses were removed. Bone 5 
marrow cells were carefully flushed out using a 23 gauge needle with ice cold HBSS and filtered 6 
through a 70 µm nylon cell strainer. Single cell suspensions were then centrifuged and 7 
resuspended in 1 ml red blood cell lysing buffer (0.16 M NH4Cl, 10 mM KHCO3, and 0.13 mM 8 
EDTA) for 5 min, followed by the addition of 5 ml of FBS and centrifuged. Cell pellets were 9 
resuspended with DMEM containing 10% FBS. Cell concentrations were determined using a 10 
Beckman Z2 Coulter Counter (Corixa, Seattle, WA).   11 
 1x107 cells were pre-incubated with signal transduction inhibitors or culture media. 12 
SB203580 (p38 MAPK inhibitor, 20 µM, Cell Signaling, Danvers, MA) or BAY11-7082 (NF-ƙB 13 
pathway inhibitor 5 µM, Cayman Chemicals, Ann Arbor, MI) was first dissolved in dimethyl 14 
sulfoxide (DMSO) and then added to the culture medium 1 hour before IL-1β stimulation. Cells 15 
were then incubated with 100 ng/ml of IL-1β, or culture media for control samples. Following IL-16 
1β stimulation, cells were washed and pelleted. Total RNA was extracted with Trizol according 17 
to the manufacturer’s protocol (Invitrogen; Carlsbad, CA). RNA was reverse transcribed to 18 
cDNA using a Reverse Transcription Kit (Promega; Madison, WI). Quantitative PCR was 19 
performed using the Applied Biosystems (Foster, CA) Assay-on-Demand Gene Expression 20 
protocol. Briefly, experimental cDNA was amplified with an ABI PRISM 7500 sequence 21 
detection system (Applied Biosystems, Foster, CA) by real-time PCR and normalized based on 22 
reference cDNA (glycerabldehyde-3-phosphate dehydrogenase; GAPDH). Data were analyzed 23 
using the comparative threshold cycle (Ct) method and results are expressed as fold difference 24 




2.10. RNA isolation and examination of restored IL-1R1 mRNA 1 
 To examine IL-1R1 mRNA expression in immune cells, spleen and bone marrow cells 2 
were isolated for RNA extraction. Spleens were dissected from wild type, IL-1R1r/r and IL-3 
1R1GR/GR animals. Bone marrow cells from the same genotypes were collected using the 4 
protocol in section 2.8. Total RNA was extracted using Trizol reagent (Invitrogen, Carlsbad, CA) 5 
according to the manufacturer’s protocol. Total RNA concentration and purity was determined 6 
by Nanodrop spectrophotometry (Denville, S. Plainfield, NJ) and reversed transcribed to cDNA 7 
using a Reverse Transcription Kit (Promega, Madison, WI). To detect the restored IL-1R1 8 
mRNA, PCR was performed using the following two pairs of primers: for amplicon EXT1 (an 9 
RNA sequence between IL-1R1 Exon IX and Exon X), EXT1F 5’-10 
GGGGCTTTATCATCCTCACG-3’ and EXT1R 5’-TCTCCCAGGGTCTTGGGATA-3’, for 11 
amplicon EXT2 (another RNA sequence between IL-1R1 Exon IX and Exon X), EXT2F 5’-12 
CCTCACGGCTACAATTGTATGC-3’ and EXT2R 5’-CAAACTGTCCCTCCAAGACC-3’. 13 
  14 
2.11. Statistical Analysis 15 
 Data were analyzed by one-way ANOVA, followed by post hoc student t-tests. When 16 
appropriate, significant main and interaction effects were subjected to Fisher’s PLSD post hoc 17 
analyses for further comparison.  An alpha level of p≤0.05 was used as the criterion for the 18 
rejection of the null hypothesis.  All data were analyzed using StatView statistical software (SAS 19 
Institute Inc., Cary, NC).  Results are reported as treatment means ± standard error of the mean 20 
(SEM). 21 
 22 
3. RESULTS 23 
Genomic DNA from putative candidate founders were digested with SacI and labeled by 24 
the 3’ probe outside the homologous recombination sequence. Blots were stripped and re-25 
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hybridized with the 5’ external probe. Animals with the IL-1R1r allele showed corresponding 1 
fragments consistent with the design.  Detailed 3’ probe and 5’ probe positions are illustrated in 2 
Fig. 1. The correct founder animal (i.e., No. 2 in Fig. 2) was used to breed for all subsequent 3 
lines.  4 
The IL-1R1r allele was detected also by PCR using two sets of primers (I, T1F1 and 5 
T1R2; II, T2F1 and T2R2). IL-1R1r was indicated by the presence of T1 amplicon (1088 bp) and 6 
T2 (440 bp) amplicon (Fig. 3A-C). Using the same forward primers (T1F1, T2F1) in combination 7 
with different reverse primers (T1R1, T2R1), the wild type sequences which correspond to the 8 
T1 and T2 locations in the IL-1R1r allele were PCR amplified. They were designated as T1WT 9 
(277 bp) and T2WT (403 bp) respectively (Fig. 3A&B). Wild type animals were detected by the 10 
presence of T1WT and T2WT but the absence of T1 and T2. Conversely, homozygote IL-1R1r/r 11 
animals were detected by the presence of T1 and T2 but not T1WT or T2WT. Heterozygote IL-12 
1R1r/+ animals were determined by the presence of both sets of amplicons. The IL-1R1 r/r mice 13 
were crossed with a Tie2Cre or a LysMCre transgenic mouse to generate Tie2Cre-IL-1R1r/r and 14 
LysMCre-IL-1R1r/r mice. In Tie2Cre-IL-1R1r/r mice, the Tie2 promoter restricts Cre recombinase 15 
expression in endothelial cells and hematopoietic cells during embryogenesis and adulthood 16 
(Constien et al., 2001) whereas in the LysMCre-IL-1R1r/r mice Cre recombinase expression is 17 
restricted in the myeloid-lineage cells (Narasimha et al., 2010). Therefore, the interfering 18 
segment target 1 was deleted in vascular and hematopoietic cells (Tie2Cre) or peripheral 19 
myeloid cells (LysMCre) respectively. In these animals, a restored IL-1R1 allele (IL-1R1R) was 20 
generated in the corresponding cell type. Cre mediated deletion leaves one loxP sequence in 21 
the IL-1R1 intron IX in the restore allele. Consequently, PCR amplification of the restored allele 22 
by T1F1 and T1R1 at the T1WT location generates an amplicon (T1WT’) with a different size. 23 
The IL-1R1R was also specifically detected by the primers LoxPF1 and T2R1, which would 24 
generate an amplicon only from the restored allele (Restored amplicon). The presence of the 25 
14 
 
Cre was detected using primers Cre300F and Cre300R. IL-1R1 globally restored animals (IL-1 
1R1GR/GR) contained homozygote IL-1R1R in the absence of Cre. Fig. 3D shows SYBR green 2 
quantitative RT-PCR of the Restored amplicon with 1 µg genomic DNA isolated from mouse tail 3 
tissue. The cycle number where the amplification curve crossed the threshold detection level 4 
reflected the amount of the restored allele in the total DNA. DNA from IL-1R1GR/GR animals had 5 
the earliest amplification, indicating that IL-1R1R in this animal was most abundant. Amplification 6 
of the Restore amplicon from an IL-1R1GR/r animal was approximately 1 cycle behind an IL-7 
1R1GR/GR animal. Thus, the amount of IL-1R1R in an IL-1R1GR/r animal was about half of that in 8 
an IL-1R1GR/GR animal, as expected.  More IL-1R1R was found in the Tie2Cre-IL-1R1r/r animal 9 
than in the LysMCre-IL-1R1r/r. This was also expected because Tie2Cre should generate IL-10 
1R1R in all hematopoietic cells whereas LysMCre should generate IL-1R1R only in a 11 
subpopulation of hematopoietic cells. Because there was no Cre mediated generation of IL-12 
1R1R in the IL-1R1r/r samples, its amplification curve was considered background noise.   13 
The IL-1R1GR/GR animal can be used as an IL-1R1 mRNA reporter animal. Fig. 4 is a 14 
collage of confocal images of coronal sections at 0.50 mm anterior to bregma taken from an IL-15 
1R1GR/GR animal. The tdTomato fluorescence shows distinct endothelial cell morphology and 16 
distribution patterns. Interestingly, the indicated IL-1R1 mRNA was mostly produced by 17 
endothelial cells from medium size blood vessels and very rarely from capillaries. They tended 18 
to be distributed throughout the brain rather than in a region specific manner. The same 19 
distribution of tdTomato fluorescence was detected in the brain tissue of Tie2Cre-IL-1R1r/r 20 
animals, but no tdTomato fluorescence was detected in wild type, IL-1R1r/r or LysMCre-IL-1R1r/r 21 
mice (data not shown). 22 
To further characterize the cell type expressing tdTomato, brain endothelial cells were 23 
extracted from IL-1R1GR/GR, IL-1R1GR/r, and IL-1R1r/r mice and examined with FACS analysis. 24 
Fig. 5A shows that approximately 11% of the enriched brain cells were CD31+ endothelial cells, 25 
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and that only 0.5% of isotype labeled cells fell within the CD31+ gate (Fig. 5A bottom). It was 1 
noted that the CD31+ population was comprised of cells with different side-scattered (SSC) 2 
distribution. These cells also displayed different forward-scattered (FSC) distribution 3 
proportional to SSC (data not shown). It is possible some of the isolated endothelial cells 4 
adhered to each other, causing increased SSC and FSC signals. Looking within the CD31+ 5 
population, Fig. 5B shows that there was a unique CD31+/tdTomato+ cell population only 6 
present in the IL-1R1GR/GR and IL-1R1GR/r mice. Subjective observation reveals that tdTomato 7 
expression was brighter in cells from IL-1R1GR/GR mice compared to IL-1R1GR/r mice. However, 8 
quantifying this by mean fluorescence intensity (MFI) was complicated by the absence of a 9 
distinct threshold between fluorescence background and actual tdTomato expression. To 10 
address this, the MFI of the top 5% brightest cells were determined. MFI of IL-1R1r/r mice (MFI: 11 
7.2) was considered to be fluorescent background. After subtracting the background from each 12 
value, the resulting values revealed that tdTomato expression was approximately twice as bright 13 
in IL-1R1GR/GR (MFI minus background: 36.3) relative to IL-1R1GR/r (MFI minus background: 14 
18.1). These data are consistent with the genotyping results, and moreover, indicate that the IL-15 
1R1 gene and tdTomato transgene exhibit a 1:1 expression ratio between copy number and 16 
gene product. Moreover, these cells also show robust tdTomato fluorescence under the 17 
microscope (Fig. 5C and D). Immune cell populations were also examined for IL-1R1 mRNA 18 
expression in the IL-1R1GR/GR animals by RT-PCR. Spleen and bone marrow cells from IL-19 
1R1GR/GR animals had undetectable tdTomato fluorescence (data not shown). To detect IL-1R1 20 
mRNA in these cells, two different target sequences, EXT1 and EXT2, were amplified. IL-1R1 21 
mRNA was detected in spleen and bone marrow cells from wild type and IL-1R1GR/GR animals 22 
but not IL-1R1r/r animals (Fig. 5E), confirming restoration of IL-1R1 in immune cells from IL-23 
1R1GR/GR animals. 24 
IHC was conducted in IL-1R1GR/GR animals to identify the cell type that expressed IL-1R1. 25 
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Results are shown in Fig. 6. Multiple-channel confocal images were 3d-reconstructed using 1 
ImageJ. In Fig. 6A, 3HA tag staining (green) revealed that IL-1R1 mRNA (red, tdTomato) and 2 
protein were expressed in the same cells but different locations at the sub-cellular level, 3 
consistent with the fact that IL-1R1 mRNA is present in the cytoplasm while IL-1R1 protein is 4 
cell membrane anchored. Double labeling of tdTomato with endothelial cell marker Ly6C shows 5 
tdTomato expressing cells were exclusively endothelial cells (Fig. 6B). Nevertheless, endothelial 6 
cells comprising capillaries did not express tdTomato. Double labeling of tdTomato with 7 
astrocyte cell marker GFAP and microglia cell marker Iba-1 showed no co-localization, 8 
indicating that astrocytes or microglia do not have detectable IL-1R1 expression under 9 
homeostatic conditions (Fig. 6 C&D).  10 
To explore cell type specific IL-1R1 functions, several responses to ICV IL-1β injections 11 
were examined in wild type, IL-1R1r/r, Tie2Cre-IL-1R1r/r, and LysMCre-IL-1R1r/r mice. Fig. 7A-D 12 
shows IL-1β induced COX-2 expression in endothelial cells 4 hrs after an ICV IL-1β injection in 13 
wild type and Tie2Cre-IL-1R1r/r mice but not IL-1R1r/r or LysMCre-IL-1R1r/r mice. Similar to COX-14 
2 induction, Fig. 7E-H shows leukocyte infiltration characterized by CD45+ cells trafficking to the 15 
brain parenchyma were also detected in wild type and Tie2Cre-IL-1R1r/r mice but not IL-1R1r/r or 16 
LysMCre-IL-1R1r/r mice 12 hrs after an ICV IL-1β injection. Iba-1 staining of microglia 24 hrs 17 
after the ICV IL-1β injection is shown in Fig. 7I-L. Microglia in the wild type, Tie2Cre-IL-1R1r/r 18 
and LysMCre-IL-1R1r/r mice exhibited de-ramified morphology, indicating an activated 19 
phenotype. In the IL-1R1r/r mice, microglia exhibited ramified morphology, indicating they were in 20 
an unstimulated resting stage. Results from IL-1 stimulated IL-1R1r/r mice were not different from 21 
those obtained in PBS injected wild type mice (data not shown). Fig. 7M and N shows that in 22 
wild type and Tie2Cre-IL-1R1r/r mice, activated microglia were detected throughout the brain 23 
parenchyma whereas in LysMCre-IL-1R1r/r mice activated microglia were confined only in the 24 
hippocampus region. Fig. 7O shows the increased proportional areas of Iba-1 after IL-1 25 
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stimulation were highest in the wild type animals, intermediate in Tie2Cre-IL-1R1r/r animals, and 1 
lowest in LysMCre-IL-1R1r/r animals (F(3,8)=5.209; p’s≤0.05). To exclude the possibility that the 2 
increased proportional area of Iba-1 was not due to reduction of microglia number in the IL-3 
1R1r/r animals, quantification of microglia number in the hippocampus was conducted. No 4 
significant difference was found in microglia number among the four genotypes (Fig. 7P). 5 
It has been previously reported that IL-1β gene expression is up-regulated by IL-1β 6 
stimulation (Dinarello, 1997). This self-amplification is mediated via IL-1R1 through NF-ƙB and 7 
p38 MAPK pathways. We examined IL-1β mRNA expression level in bone marrow cells from 8 
wild type, IL-1R1r/r, Tie2Cre-IL-1R1r/r, LysMCre-IL-1R1r/r and IL-1R1GR/GR mice following ex vivo 9 
IL-1β challenge (100 ng/ml). Fig. 8 shows significant elevation of IL-1β mRNA was detected in 10 
the bone marrow cells from wild type, Tie2Cre-IL-1R1r/r, LysMCre-IL-1R1r/r and IL-1R1GR/GR mice, 11 
but not IL-1R1r/r mice, 24 hrs after IL-1β stimulation (p’s ≤0.05 for wild type, Tie2Cre-IL-1R1r/r, 12 
LysMCre-IL-1R1r/r and IL-1R1GR/GR mice). The induction of IL-1β mRNA was blocked by NF-ƙB 13 
pathway inhibitor BAY11-7082 and p38 MAPK pathway inhibitor SB203580, indicating these 14 
signal transduction pathways were also restored in specific cell types. 15 
4. DISCUSSION 16 
In the present study we produced an IL-1R1r/r animal model using knockin strategy. In 17 
the IL-1R1r/r mouse, IL-1-induced CNS effects including brain COX-2 expression, leukocyte 18 
trafficking, microglia activation, and IL-1-induced peripheral effects such as the induction of IL-19 
1β in bone marrow cells, were all abolished. This is consistent with our design that the IL-1R1r/r 20 
animals should display an IL-1R1 deficient phenotype.  In addition, IL-1R1 was restored in the 21 
endothelial cells and hematopoietic cells in the Tie2Cre-IL-1R1r/r and myeloid cells in the 22 
LysMCre-IL-1R1r/r mice as expected. An IL-1R1GR/GR mouse was also obtained and worked as 23 
an IL-1R1 mRNA and protein reporter animal. Therefore, this genetic model fulfilled all of the 24 
goals of our design.  25 
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 In fact, the IL-1R1r/r mouse could serve as a more complete IL-1R1 gene knockout. 1 
Previously two IL-1R1 knockout mouse lines were generated (Glaccum et al., 1997; Labow et 2 
al., 1997). However, a recent study showed that in these models a shortened IL-1R1 mRNA can 3 
still be expressed due to the existence of an internal promoter in the IL-1R1 gene that is 4 
unaffected in the knockouts. This shortened IL-1R1 mRNA can produce IL-1R3 in neural tissues, 5 
which is involved in IL-1 induced electrophysiological effects (Qian et al., 2012). In our IL-1R1 6 
restore construct, an interfering DNA segment comprised of three disrupting elements was 7 
inserted into the intron IX of IL-1R1 gene. The three elements, En2, DD and 2PolyA sequence 8 
have different and independent mechanisms to ensure the destabilization of IL-1R1 mRNA and 9 
disruption of IL-1R1 exons X and XI translation. IL-1R1 exons X and XI encode the 10 
transmembrane (TM, see Fig.1) and cell signaling domain of IL-1R1 protein which are essential 11 
for the normal IL-1R1 functions. By this design, the IL-1R1r/r animal should not have any residual 12 
IL-1R1 gene product, therefore, is a better IL-1R1 knockout.  13 
 Using the IL-1R1GR/GR animal as an IL-1R1 mRNA reporter animal, the IL-1R1 mRNA 14 
distribution in the brain was mapped by tdTomato fluorescence with high resolution confocal 15 
microscopy. This is the first time that IL-1R1 mRNA was visualized by a tracer molecule in the 16 
CNS.  Results reveal IL-1R1 mRNA producing cells in the brain have endothelial cell 17 
morphology and are present in medium-size blood vessels. Cells with tdTomato expression 18 
were not found in other cell types. This observation is consistent with previous results that IL-19 
1R1 mRNA is found in endothelial cells by ISHH, but inconsistent with the detection of IL-1R1 20 
mRNA in neurons in select regions (Ericsson et al., 1995). This discrepancy could be explained 21 
by the following facts. First, the previous ISHH studies were done on rat tissues, whereas our 22 
study was conducted in mice. The species differences may contribute to the variation of IL-1R1 23 
mRNA level in neurons. Second, the identification of IL-1R1 mRNA in neurons by ISHH was 24 
based on morphology, not on double labeling with specific neuronal markers. It is possible the 25 
ISHH identification of neuronal IL-1R1 mRNA was not definitive. Another possibility is that the 26 
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riboprobe used by Ericsson et al. recognized both IL-1R1 on endothelial cells and IL-1R3 on 1 
neurons. In contrast, in the present study, expression of extremely low levels of IL-1R3 may be 2 
below the detection limit of tdTomato, leaving neuronal IL-1R3 undetected. Nevertheless, the 3 
high IL-1R1 mRNA expressing cells appear to be endothelial cells in the CNS. Additionally, IL-4 
1R1 mRNA expression levels were shown to be up-regulated following IL-1 stimulation 5 
(Proescholdt et al., 2002) and down-regulated in other pathological conditions (Nishida et al., 6 
2004). With the tdTomato tracer for IL-1R1 mRNA, our IL-1R1GR/GR animals can potentially be 7 
used for visual quantitative analysis of IL-1R1 mRNA regulation. Co-localization of the tdTomato 8 
expressing cells with endothelial cell marker Ly6C confirmed that cells expressing IL-1R1 9 
mRNA are definitively brain endothelial cells. Interestingly, we observed that most capillaries 10 
labeled by Ly6C did not express tdTomato fluorescence, similar to the lack of IL-1R1 mRNA 11 
labeling in brain capillaries observed by Ericsson et al. (Ericsson et al., 1995). In the periphery, 12 
it is well-known that IL-1R1 is expressed in the macrophages, T cells and other immune cells 13 
(Sims et al., 1988). In our model, the restoration of IL-1R1 expression in the immune cells from 14 
the IL-1R1GR/GR animals was verified by the presence of IL-1R1 mRNA transcript. Failure to 15 
observe any tdTomato fluorescence in these cells indicates that IL-1R1 expression is 16 
maintained at very low levels under physiological conditions. In terms of immunohistochemical 17 
detection of IL-1R1 protein, most previous studies failed to detect IL-1R1-ir in the normal brain. 18 
After up-regulation of IL-1R1 protein expression following electrical stimulation in the 19 
hippocampus or immune challenge by intraperitoneal LPS injection, IL-1R1-ir became 20 
detectable (Ravizza and Vezzani, 2006; Matsuwaki et al., 2014). In the present study, the 21 
restored IL-1R1 was tagged by the 3HA epitope and readily detected by IHC in the normal brain. 22 
Notably, the labeling patterns of 3HA in the normal brain resemble the pattern of IL-1R1-ir 23 
observed by Matsuwaki et al. in LPS treated animals. Thus, the detection of IL-1R1 protein is 24 
significantly enhanced by the use of 3HA epitope tracer. In regard to the identification of IL-1R1 25 
expressing cell types, previous IHC studies have generated discrepant results.  IL-1R1-ir was 26 
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found only in endothelial cells in some studies (Konsman et al., 2004; Ravizza and Vezzani, 1 
2006; Ching et al., 2007), only in hippocampal neurons (French et al., 1999), or in hippocampal 2 
neurons and astrocytes (Ravizza and Vezzani, 2006) in other studies. These discrepancies are 3 
still difficult to explain. Nonetheless, in our IL-1R1GR/GR animal, 3HA tagged IL-1R1 protein is 4 
expressed in the same cells in which IL-1R1 mRNA is tracked by tdTomato fluorescence. 5 
Therefore, the concordant labeling of IL-1R1 mRNA and protein achieved in this model could 6 
help avoid potential artifacts in IL-1R1-ir detection.  7 
 Our results show the IL-1R1 mRNA producing cells from the IL-1R1GR/GR animal can be 8 
enriched and analyzed by FACS analysis. Robust tdTomato fluorescence was detected in a 9 
small percentage of isolated brain endothelial cells. Previously, isolated CNS cell types in 10 
primary cultures were used to study IL-1R1 mediated signaling (Srinivasan et al., 2004). In 11 
these cultures, it is likely that IL-1R1 expressing cells are mixed with IL-1R1 non-expressing 12 
cells, rendering assessment of direct IL-1R1 signaling effects difficult. Because IL-1R1 13 
expressing cells from our IL-1R1GR/GR animal can be enriched and FACS sorted, it is now 14 
possible to specifically study IL-1R1 mediated effects from IL-1 expressing cells.  15 
 Interesting results emerged when we compared IL-1 stimulated effects in the Tie2Cre-IL-16 
1R1r/r vs. LysMCre-IL-1R1r/r animals. After ICV IL-1β injection, endothelial COX-2 induction, 17 
leukocyte infiltration, and global activation of brain microglia, which have been found previously 18 
in wild type animals (Basu et al., 2002; Proescholdt et al., 2002), disappeared in the IL-1R1r/r 19 
animals, but re-emerged in the Tie2Cre-IL-1R1r/r animals. In contrast, ICV IL-1β failed to induce 20 
COX-2 expression and leukocyte infiltration in the LysMCre-IL-1R1r/r animals. In peripheral bone 21 
marrow cells, IL-1β-stimulated IL-1β expression was absent in the IL-1R1r/r animals but was 22 
rescued in both Tie2Cre-IL-1R1r/r and LysMCre-IL-1R1r/r animals. These results indicate 23 
restoring IL-1R1 in peripheral immune cells is not sufficient for central IL-1β stimulated 24 
leukocyte infiltration and COX-2 expression, whereas restoring IL-1R1 on brain endothelial cells 25 
is both sufficient and necessary for the central IL-1β-induced COX-2 expression, leukocyte 26 
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infiltration, and global microglia activation. These results corroborate the conclusions from 1 
previous studies using two endothelial specific IL-1R1 knockdown mouse models that 2 
endothelial IL-1R1 mediates central IL-1 induced COX-2 expression and leukocyte infiltration 3 
(Ching et al., 2007; Li et al., 2011). This is further supported by a recent report that peripheral 4 
IL-1β induced COX-2 expression in brain endothelial cells mediates febrile response (Wilhelms 5 
et al., 2014). A novel observation in the present study is that endothelial IL-1R1 alone is 6 
sufficient to mediate microglia activation. It should be noted, Serrats et al. have suggested that 7 
perivascular macrophages, in addition to endothelial cells, contributes significantly to central IL-8 
1 mediated HPA-axis activation (Saper, 2010; Serrats et al., 2010), whereas IL-1R1 expression 9 
was not detected in perivascular macrophages in the present study. The studies by Serrats et 10 
al., however, were performed in the rats. In a recently published paper, Matsuwaki et al. showed 11 
that IL-1R1 on non-hematopoietic cells (most likely endothelial cells), not perivascular 12 
macrophages, are responsible for IL-1β induced HPA-axis activation in mice (Matsuwaki et al., 13 
2014). Thus, our results are consistent with this more recent report, indicating perivascular 14 
macrophages do not play a critical role in mediating central IL-1 effects, at least in mice. The 15 
lack of detection of tdTomato fluorescence in non-endothelial CNS cell types in our IL-1R1GR/GR 16 
animals, however, does not exclude the possibility that IL-1R1 might still be expressed at very 17 
low levels in other CNS cell types, as in peripheral immune cells. Therefore, in the future, 18 
combining IL-1R1r/r animals with other CNS cell type specific Cre animals, such as CX3CR1-Cre 19 
or GFAP-Cre mice, may lead to discoveries of additional IL-1R1 mediated cell type specific 20 
effects.  21 
Surprisingly, in the LysMCre-IL-1R1r/r animals, ICV IL-1β induced microglia activation 22 
which was confined in the hippocampal area. One possibility for this observation was a 23 
subpopulation of microglia cells in the hippocampus expressed a small amount of IL-1R1 after 24 
LysM Cre mediated restore. It has been shown previously peripheral monocytes may migrate 25 
into the brain parenchyma and differentiate into a microglia-like population under certain 26 
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conditions (Varvel et al., 2012). Since LysM promoter is not active in the yolk sac derived 1 
microglia or other cell types in the brain (Fantin et al., 2010), it is possible that hippocampus 2 
harbors a unique subpopulation of hematopoietically derived microglia during development. 3 
These microglia may have their IL-1R1 restored by LysM Cre and become activated after ICV 4 
IL-1β injection. This interesting possibility remains to be verified.  5 
 In summary, the present study demonstrates a powerful genetic mouse model to study 6 
cell type specific IL-1R1 mediated responses. This model allows IL-1R1 to be expressed in 7 
predetermined cell types and tracked by tdTomato fluorescence and 3HA tagging. With this 8 
model IL-1R1 expressing cells can be easily visualized and isolated. In the normal brain 9 
endothelial cells in medium size blood vessels were found to be the major producers of IL-1R1 10 
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Figure 1.  Schematic illustrations of IL-R1 wild type (top) and restore knockin (bottom) 1 
alleles. Top, relevant sequence of IL-1R1 gene containing exon IX, X, and XI. Short arm for 2 
homologous recombination is designed from intron VIII to intron IX. Long arm for homologous 3 
recombination is designed from exon XI to the 3’ non-coding region. In the restore allele, 4 
knockin Target I and knockin Target II are inserted into the IL-1R1 locus. Target I DNA segment 5 
contains an En2 sequence, a destabilization domain (DD), and 2 polyA signal sequence 6 
followed by a Neo cassette.  Target I segment is flanked by two loxP sites. Knockin Target II is 7 
placed at the stop codon of the IL-1R1 sequence. The original stop codon is replaced by 3HA-8 
STOP-IRES-tdTomato-STOP. Positions of the probes for Southern Blot analysis are shown with 9 
the red arrows. The 5’ probe and 3’ probe detects a 15kb fragment and an 8.7kb fragment 10 
respectively in the restore allele after SacI digestion, but a 22.4kb fragment in the wild type. TM 11 
= transmembrane. 5’-Prb, 5’ probe. 3’-Prb, 3’ probe. En2 SA, Engrailed-2 splice acceptor 12 
sequence. DD, destabilization domain. 2PolyA, 2PolyA sequence. neo, Neo cassette. 3HAs, 13 
3HA tag sequence. IRES, IRES sequence. tdTomato, tdTomato sequence. SacI, restriction 14 




























Figure 2. Southern blot results of homologous recombination in the putative founders. 1 
Genomic DNA from putative founder animals (1, 2, 3, 4, are animal numbers) was probed with 3’ 2 
probe first (left). Blots were then stripped and re-probed with 5’ probe (right). Candidate animal 3 
No.2 carried the targeted knockin construct evidenced by a 15 kb fragment and 8.7 kb fragment 4 







































Figure 3. Primer design for detection of knockin allele and genotyping identification. (A) 1 
Top: Genomic organization of exon IX, X and XI in the wild type IL-1R1 allele. Middle: knockin 2 
IL-1R1 allele after homologous recombination. Bottom: restored IL-1R1 allele after Cre 3 
recombinase mediated excision of the disrupting sequence. Black triangles indicate loxP 4 
sequence and primer design is shown by black arrows. Sequence length represented by bars in 5 
the schematic has been adjusted for better illustration. Dashed lines indicate primer locations in 6 
the allele. (B) Table of designations of target amplicons, their corresponding sizes, and primers. 7 
(C) Genotyping results of animals carrying different IL-1R1 alleles. (D) SYBER green 8 
quantitative RT-PCR with primers LoxPF1 and T1R1 on 1 µg mouse tail DNA from animals with 9 
different genotypes. Different amount of the Restore amplicon were detected in the same 10 
amount of total genomic DNA from either an IL-1R1GR/GR animal or a cell type specific IL-1R1 11 
restored animals. Red dots indicate the coordinate (amplification cycle number) of the 12 
amplification curve that crossed the threshold of SYBER green detection level. The threshold 13 
detection level of specific amplification of our real-time PCR machine is 32 cycles as shown by 14 



























Figure 4. Representative distribution map of IL-1R1 mRNA expressing cells. IL-1R1 mRNA 1 
distribution was mapped by a collage of a representative brain sections obtained from an IL-2 
1R1GR/GR animal. IL-1R1 mRNA expression was tracked by tdTomato fluorescence. Scale bar = 3 






































Figure 5. Analysis of IL-1R1 mRNA producing cells in the CNS and periphery. (A) 1 
Percentage of CD31 positive brain endothelial cells. (B) Representative flow bivariate dot plots 2 
of CD31/tdTomato labeling of enriched brain endothelial cells from IL-1R1GR/GR, IL-1R1GR/r, or IL-3 
1R1r/r animals. Mean Fluorescence Intensity (MFI) was calculated for the top 5% brightest cells 4 
labeled with tdTomato. (C&D) Enriched brain endothelial cells taken from IL-1R1GR/GR and IL-5 
1R1r/r animals. White arrows indicate the tdTomato fluorescence in endothelial cells from an IL-6 
1R1GR/GR animal. Scale bar = 25 µm. (E) PCR results of IL-1R1 mRNA amplification in spleen 7 
and bone marrow cells from wild type, IL-1R1r/r, or IL-1R1GR/GR animals. BM, bone marrow; 8 
EXT1, an IL-1R1 mRNA amplicon from Exon IX to Exon X, 199 bp; EXT2, another IL-1R1 9 

































Figure 6. Identification of brain IL-1R1 mRNA expressing cell types. Brain sections from an 1 
IL-1R1GR/GR animal were labeled with 3HA (A) Ly6C (B), GFAP (C), and Iba-1(D). Pictures were 2 
taken using a confocal microscope and were 3d-reconstucted with image stacks. Scale bar = 25 3 































Figure 7. IHC labeling of COX-2, CD45, and Iba-1 following an ICV injection of IL-1β. Brain 1 
sections from a wild type animal,  IL-1R1r/r animal,  Tie2Cre-IL-1R1r/r animal, and LysMCre-IL-2 
1R1r/r animal following an ICV injection of IL-1β were labeled with COX-2 (A-D), CD45 (E-H), 3 
and Iba-1 (I-L). Representative distribution pattern of Iba-1 labeled cells in a wild type or 4 
Tie2Cre-IL-1R1r/r animal (M) and a LysMCre-IL-1R1r/r animal (N). Red indicates Iba-1 labeled 5 
cells.  Coronal sections of mouse brains were taken at 1.70 mm posterior to bregma. Scale bar 6 
25um. (O) Quantification of fluorescence intensity in the hippocampal area (square box). Bars 7 
represent group means±SEM. Differing letters (i.e., a, b, or c) represent significant difference 8 
between groups (p’s ≤ 0.05). HPC, hippocampus. (P) Quantification of microglia numbers in the 9 
































Figure 8. RT-PCR analysis of IL-1β mRNA levels in bone marrow cells following ex vivo 1 
IL-1β stimulation. Bone marrow cells isolated from wild type, IL-1R1r/r Tie2Cre-IL-1R1r/r, 2 
LysMCre-IL-1R1r/r and IL-1R1GR/GR animals were incubated with SB203580 (p38 MAPK inhibitor), 3 
BAY11-7082 (NF-ƙB inhibitor) or culture media for 1 hour and challenged with 100 ng/ml IL-1β. 4 
IL-1β mRNA was analyzed 24h after IL-1β treatment. Bars represent group means±SEM. * 5 
represent significant difference between control and experimental group (p’s ≤ 0.05). 6 
